{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:02:03Z","timestamp":1793037723856,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jasc.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:17:37Z","timestamp":1588720657000},"page":"550-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women\u2019s hospital laboratory"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-5875","authenticated-orcid":false,"given":"Dayne","family":"Ashman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-1601","authenticated-orcid":false,"given":"Dinesh","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.04.010_bib1","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.ijgo.2015.06.004","article-title":"Cancer of the cervix uteri","volume":"131","author":"Bermudez","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jasc.2020.04.010_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0020-7292(97)02859-2","article-title":"Impact of cancer screening on women's health","volume":"58","author":"Elovainio","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jasc.2020.04.010_bib3","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2020.04.010_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2020.04.010_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib6","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2020.04.010_bib7","first-page":"755","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jasc.2020.04.010_bib8","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2020.04.010_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2020.04.010_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jasc.2020.04.010_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.04.010_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jasc.2019.01.001","article-title":"HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests","volume":"8","author":"Ge","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5858\/arpa.2014-0028-OA","article-title":"Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study","volume":"139","author":"Zhao","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.04.010_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncy.21687","article-title":"Clinical performance of the Food and Drug Administration-approved high-risk HPV test for the detection of high-grade cervicovaginal lesions","volume":"124","author":"Zhou","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.04.010_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1309\/GCVB5C4KFV7TFC7F","article-title":"Laboratory management of CIN 2: the consensus is consensus","volume":"130","author":"Crum","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","article-title":"Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia","volume":"133","author":"Bergeron","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M14-2426","article-title":"Cervical cancer screening in average-risk women: best practice advice from the clinical guidelines committee of the American College of Physicians","volume":"162","author":"Sawaya","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jasc.2020.04.010_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"C Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jasc.2020.04.010_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0000000000000479","article-title":"What role should cytology play in cervical cancer screening?","volume":"23","author":"Perkins","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.04.010_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cervical cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.04.010_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2020.04.010_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ijc.29053","article-title":"Sensitivity, effect and over-diagnosis in screening for cancers with detectable pre-invasive phase","volume":"136","author":"Hakama","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.04.010_bib25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.27850","article-title":"The HPV test has similar sensitivity but more overdiagnosis than the Pap test\u2014a randomized health services study on cervical cancer screening in Finland","volume":"132","author":"Malila","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.04.010_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2020.04.010_bib27","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","article-title":"A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer","volume":"13","author":"Castle","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"suppl 1","key":"10.1016\/j.jasc.2020.04.010_bib28","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jasc.2020.04.010_bib29","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2020.04.010_bib30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncy.21875","article-title":"Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer","volume":"125","author":"Ge","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/dc.23959","article-title":"High grade squamous intraepithelial lesion on high-risk HPV negative patients: why we still need the Pap test","volume":"46","author":"Sun","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cncy.20176","article-title":"Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results","volume":"119","author":"Gao","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/aqx027","article-title":"Polymerase chain reaction human papillomavirus (HPV) detection and HPV genotyping in invasive cervical cancers with prior negative HC2 test results","volume":"147","author":"Tao","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.04.010_bib34","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.18632\/oncotarget.14533","article-title":"Identification and characterization of HPV-independent cervical cancers","volume":"8","author":"Banister","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jasc.2020.04.010_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cncr.22688","article-title":"Significance and possible causes of false-negative results of reflex human Papillomavirus infection testing","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.04.010_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/aqy114","article-title":"Enhanced detection of cervical cancer and precancer through use of imaged liquid-based cytology in routine cytology and HPV cotesting","volume":"150","author":"Austin","year":"2018","journal-title":"Am J Clin Pathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:47:42Z","timestamp":1761979662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2213294520300740"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.04.010","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women\u2019s hospital laboratory","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}